Lijun Yang

127 Changle West Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.

The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.

Journal: International journal of biological sciences

Published: January 27, 2026

Development and external validation of a pragmatic nomogram for point-of-care urolithiasis screening in resource-limited settings of Laos: a multicenter retrospective cohort study.

Development and external validation of a pragmatic nomogram for point-of-care urolithiasis screening in resource-limited settings of Laos: a multicenter retrospective cohort study.

Journal: PeerJ

Published: December 30, 2025

Correction: Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Correction: Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Journal: Frontiers in immunology

Published: November 06, 2025

rTMS for rapid relief of sleep disorders induced by influenza virus infection: a clinical retrospective study.

rTMS for rapid relief of sleep disorders induced by influenza virus infection: a clinical retrospective study.

Journal: Translational psychiatry

Published: October 13, 2025

GRIN3A defines an immunosuppressive niche in advanced prostate cancer.

GRIN3A defines an immunosuppressive niche in advanced prostate cancer.

Journal: Medical oncology (Northwood, London, England)

Published: September 09, 2025

Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Journal: Frontiers in immunology

Published: July 10, 2025

Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.

Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.

Journal: Journal for immunotherapy of cancer

Published: March 12, 2025

The role of inflammation and ROS in CaOx kidney stones.

The role of inflammation and ROS in CaOx kidney stones.

Journal: European journal of medical research

Published: March 05, 2025

The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer.

The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer.

Journal: International journal of biological sciences

Published: December 30, 2024

Endosialin promotes vascular maturation by inhibiting Cyr61 expression in melanoma metastasis.

Endosialin promotes vascular maturation by inhibiting Cyr61 expression in melanoma metastasis.

Journal: Frontiers in oncology

Published: November 14, 2024

Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study.

Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study.

Journal: Advances in therapy

Published: September 13, 2023

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma.

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: April 20, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026